Lead Optimization Resources in Drug Discovery for Diabetes.

Published on Sep 3, 2019in Endocrine‚ Metabolic & Immune Disorders-Drug Targets1.104
· DOI :10.2174/1871530319666190304121826
Pragya Tiwari1
Estimated H-index: 1
Ashish Katyal (Meerut Institute of Engineering and Technology)+ 2 AuthorsKhurshid Ahmad9
Estimated H-index: 9
(Yeungnam University)
  • References (0)
  • Citations (0)
📖 Papers frequently viewed together
2 Authors (C.K Atterwill, M.G Wing)
78% of Scinapse members use related papers. After signing in, all features are FREE.
#1Elin Høien Bergene (NTNU: Norwegian University of Science and Technology)H-Index: 1
#2Hedvig Nordeng (University of Oslo)H-Index: 29
Last. Aslak Steinsbekk (NTNU: Norwegian University of Science and Technology)H-Index: 21
view all 4 authors...
#1N. H. Cho (International Diabetes Federation)H-Index: 40
#2Jonathan E. ShawH-Index: 96
Last. Belma Malanda (International Diabetes Federation)H-Index: 7
view all 7 authors...
Abstract Introduction Since the year 2000, IDF has been measuring the prevalence of diabetes nationally, regionally and globally. Aim To produce estimates of the global burden of diabetes and its impact for 2017 and projections for 2045. Methods A systematic literature review was conducted to identify published studies on the prevalence of diabetes, impaired glucose tolerance and hyperglycaemia in pregnancy in the period from 1990 to 2016. The highest quality studies on diabetes prevalence were ...
453 CitationsSource
#1Mursheda Begum (Guy's Hospital)H-Index: 3
#2Grant Lewison (Guy's Hospital)H-Index: 18
Last. Richard Sullivan (Guy's Hospital)H-Index: 30
view all 6 authors...
Aim This study examined the outputs of research papers in diabetes from 31 European countries between 2002 and 2013, and their funding. Methods Diabetes research papers in the Web of Science were identified by means of a filter based on journals and title words. For 2009–2013 papers, the funders were coded to show their sector and nationality. Results Europe published 40 547 diabetes papers in the 12 years between 2002 and 2013. Denmark, Sweden and Finland published the most relative to their we...
6 CitationsSource
Abstract Diabetes has increased at an unprecedented rate and is fast emerging as a global threat worldwide. The focus on pharmacological studies pertaining to diabetes has seen a remarkable shift from conventional medicines to therapeutics employing bioactive phytomolecules from natural sources. The prospective effectiveness of natural products together with their low cost and minimal side effects has revolutionized the entire concept of drug discovery and management programs. One such beneficia...
1 CitationsSource
#1Sarah Wild (Edin.: University of Edinburgh)H-Index: 4
#2Colin FischbacherH-Index: 30
Last. John McKnight (Western General Hospital)H-Index: 24
view all 3 authors...
There are an increasing number of clinical, administrative and trial databases that can be used for research. These are particularly valuable if there are opportunities for linkage to other databases. This paper describes examples of the use of large diabetes databases for research. It reviews the advantages and disadvantages of using large diabetes databases for research and suggests solutions for some challenges. Large, high-quality databases offer potential sources of information for research...
3 CitationsSource
#1Sunghwan Kim (NIH: National Institutes of Health)H-Index: 15
#2Paul A. Thiessen (NIH: National Institutes of Health)H-Index: 15
Last. Stephen H. Bryant (NIH: National Institutes of Health)H-Index: 5
view all 14 authors...
PubChem ( is a public repository for information on chemical substances and their biological activities, launched in 2004 as a component of the Molecular Libraries Roadmap Initiatives of the US National Institutes of Health (NIH). For the past 11 years, PubChem has grown to a sizable system, serving as a chemical information resource for the scientific research community. PubChem consists of three inter-linked databases, Substance, Compound and BioAssay. The Subs...
1,052 CitationsSource
#1Pragya Tiwari (Central Institute of Medicinal and Aromatic Plants)H-Index: 2
Diabetes highlights a growing epidemic imposing serious social economic crisis to the countries around the globe. Despite scientific breakthroughs, better healthcare facilities, and improved literacy rate, the disease continues to burden several sections, especially middle and low income countries. The present trends indicate the rise in premature death, posing a major threat to global development. Scientific and technological advances have witnessed the development of newer generation of drugs ...
16 CitationsSource
Diabetes accounts for high mortality rate worldwide affecting million of lives annually. Global prevalence of diabetes and its rising frequency makes it a key area of research in drug discovery programs. The research article describes the development of quantitative structure activity relationship model against PPARγ, a promising drug target for diabetes. Multiple linear regression approach was adopted for statistical model development and the QSAR relationship suggested the regression coefficie...
#1Juan Pablo Domecq (UPCH: Cayetano Heredia University)H-Index: 15
#2Gabriela Prutsky (UPCH: Cayetano Heredia University)H-Index: 13
Last. M. Hassan Murad (UR: University of Rochester)H-Index: 94
view all 17 authors...
Context: Various drugs affect body weight as a side effect. Objective: We conducted this systematic review and meta-analysis to summarize the evidence about commonly prescribed drugs and their association with weight change. Data Sources: MEDLINE, DARE, and the Cochrane Database of Systematic Reviews were searched to identify published systematic reviews as a source for trials. Study Selection: We included randomized trials that compared an a priori selected list of drugs to placebo and measured...
108 CitationsSource
1 CitationsSource
Cited By0
#1Fahmida Alam (Universiti Sains Malaysia)H-Index: 8
#2Mohammad A. Kamal (KAU: King Abdulaziz University)H-Index: 28
Last. Shaheena BanuH-Index: 4
view all 4 authors...